HomeFile

File

View Category
Antiplatelet

Secondary Prevention with P2Y12 Inhibitors: How Consolidated Is This Long Term Alternative vs. Aspirin?

Secondary prevention with P2Y12 inhibitors vs aspirin monotherapy in CAD patients Antiaggregation therapy plays a central role at...
solaci -
Learn More
Coronary disease

Simplified Rapid Intravenous Hydration for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease

Patients with chronic kidney disease (CKD) undergoing coronary angiography are at increased risk of developing contrast-associated acute...
solaci -
Learn More
Chronic Coronary Syndromes

What Is the Prognosis of an Acute Myocardial Infarction in the Presence of Moderate Aortic Stenosis?

Aortic stenosis (AS) is a common condition that shares risk factors with coronary artery disease. Many patients...
solaci -
Learn More
Structural heart disease

TAVR Durability at 5 Years in Intermediate Risk Patients

TAVR has been shown beneficial in patients across the risk spectrum. The PARTNER 2 SAPIEN 3 (P2S3i)...
solaci -
Learn More
Mitral valve

Is Edge-to-Edge Treatment with PASCAL Effective at 3 Years?

Mitral regurgitation is the most common valvular heart disease. Its cause is most frequently functional or secondary...
solaci -
Learn More
Coronary disease

Relationship between Distal Vessel Quality and Outcomes in the Treatment of Chronic Total Occlusions

Percutaneous treatment of chronic total occlusions has increase, and has become a a more habitual therapeutic challenge....
solaci -
Learn More
Mitral valve

Cerebrovascular Events in the COAPT Study

Transcatheter edge-to-edge repair (TEER) with MitraClip has demonstrated its benefit compared with complete guideline-directed medical therapy (GDMT),...
solaci -
Learn More
Structural heart disease

Transcatheter Mitral Valve Replacement vs. Medical Therapy

Mitral valve regurgitation (MR) is a common cause behind heart failure and is associated to hospitalization for...
solaci -
Learn More